IDiyas

For the Inventor, By the Inventor

Ballerup, Denmark

Leo-pharma A/s


USPTO Granted Patents = 67



Trademarks = 40

Forward Citations = 187

Loading Chart...
Loading Chart...

177 inventors (with patents filed for the assignee):

goldMedal Karsten Petersson (10 out of 10 patents)

silverMedal Simon Feldbæk Nielsen (10 out of 13 patents)

bronzeMedal Jens Munk Hansen (8 out of 19 patents)

4.  Marianne Lind (8 out of 8 patents)

5.  Gritt Rasmussen (8 out of 8 patents)

6.  Mette Rydahl Sonne (8 out of 9 patents)

7.  Xifu Liang (7 out of 17 patents)

8.  Jakob Felding (7 out of 31 patents)

9.  Mogens Larsen (5 out of 5 patents)

10.  Patrick Stephen Johnson (5 out of 5 patents)

11.  Simon Feldbaek Nielsen (5 out of 22 patents)

12.  Anne Marie Horneman (5 out of 9 patents)

13.  Bjarne Nørremark (5 out of 8 patents)

14.  Daniel Rodriguez Greve (5 out of 14 patents)

15.  Kevin Neil Dack (4 out of 4 patents)


Core Competencies:
IL-17 Modulators
JAK Kinase Inhibitors
Phosphodiesterase Inhibitors
Vitamin D Analogue
Corticosteroid Composition
Neurokinin 1 Receptor Antagonists
Heterocyclic Compounds
Protein Tyrosine Kinase Inhibitors
Calcium Sensing Receptor Modulators
Topical Drug Delivery
Synthetic Intermediates
Film-Forming Polymers

67 patents:

1. 12195481 - Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereof (2025-01-14),
2. 12065429 - Small molecule modulators of IL-17 (2024-08-20),
3. 12043669 - IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereof (2024-07-23),
4. 11673900 - Process for preparing 7H-pyrrolo[2,3-d]pyrimidine derivatives and synthetic intermediates thereof (2023-06-13),
5. 11377425 - Small molecule modulators of IL-17 (2022-07-05),
6. 11065257 - Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors (2021-07-20),
7. 10934282 - Heteroaromatic modulators of the retinoid-related orphan receptor gamma (2021-03-02),
8. 10906915 - Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors (2021-02-02),
9. 10851116 - Bicyclic amines as novel JAK kinase inhibitors (2020-12-01),
10. 10799507 - 5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitors (2020-10-13),
11. 10793580 - Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitors (2020-10-06),
12. 10716799 - Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid (2020-07-21),
13. 10703751 - Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereof (2020-07-07),
14. 10688108 - Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid (2020-06-23),
15. 10682364 - Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid (2020-06-16),
LEO Pharma A/S is a global pharmaceutical company specializing in dermatology and critical care. With over 100 years of experience, LEO Pharma develops and markets innovative solutions to help people achieve healthier skin. The company is committed to improving the lives of patients by advancing precision medicine, supporting scientific research, and providing educational resources to healthcare professionals. Visit their website for more information and to discover their range of products and services.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
67 Patents

#6 in Ballerup

#51 in Denmark

#10,592 in the World

...
Ballerup, Denmark

Leo-pharma A/s

Forward Citations = 187

177 inventors:

goldMedal Karsten Petersson (10 out of 10 patents)

silverMedal Simon Feldbæk Nielsen (10 out of 13 patents)

bronzeMedal Jens Munk Hansen (8 out of 19 patents)

4.  Marianne Lind (8 out of 8 patents)

5.  Gritt Rasmussen (8 out of 8 patents)

Please report any incorrect information to support@idiyas.com
Loading…